Latest Food and Drug Administration Stories
Although recently approved by the FDA, the potential effectiveness of the new Maestro implantable weight loss surgery device leaves questions in the minds of many, leading people to take a second
Nevro to Host Investor Conference Call Friday, January 23 at 8:30 a.m. ET MENLO PARK, Calif., Jan. 22, 2015 /PRNewswire/ -- Nevro Corp.
NORTHBROOK, Ill., Jan. 22, 2015 /PRNewswire/ -- Astellas today announced that the U.S.
Funds to Advance Novel Biologic Pipeline and Internal Operations SHANGHAI, Jan.
NEWPORT BEACH, Calif., Jan.
A global solution for the numerous countries adopting GS1-based serialization requirements PALO ALTO, Calif., Jan.
TUCSON, Ariz., Jan. 21, 2015 /PRNewswire/ -- Ventana Medical Systems, Inc.
ATLANTA, Jan. 21, 2015 /PRNewswire/ -- CryoLife, Inc.
EFSA: "NO CONSUMER HEALTH RISK FROM BISPHENOL A EXPOSURE" WASHINGTON, Jan.
FDA marketing scrutiny no longer is limited to magazine and TV ads.
Flavr Savr, also known as CGN-89564, a genetically modified tomato, was the first commercially grown genetically engineered food to be granted a license for human consumption. It was produced by the Californian company Calgene, and submitted to the U.S. Food and Drug Administration in 1992. On May 18, 1994, the FDA completed its evaluation of the Flavr Savr tomato and the usage of APH(3’)II, concluding that the tomato “is as safe as tomatoes bred by conventional means” and “that the...
The Chilean sea bass is the North American name for the Patagonian toothfish. The Chilean sea bass name derived in 1977 from Lee Lantz, a fish wholesaler looking for a more attractive name for the American fish market. In 1994 the Food and Drug Administration (FDA) accepted the Chilean sea bass as an alternative name for the Patagonian toothfish. This species is native to the southern Pacific, Atlantic, and Indian Oceans, around seamounts and continental shelves in the colder waters. The...